imatinib mesylate has been researched along with von Willebrand Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, T; Uchiyama, M | 1 |
1 other study(ies) available for imatinib mesylate and von Willebrand Diseases
| Article | Year |
|---|---|
Successful imatinib mesylate therapy for acquired von Willebrand syndrome in chronic myelogenous leukemia.
Topics: Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines; von Willebrand Diseases | 2009 |